文献速递神经免疫

端粒长度与多发性硬化残疾进展相关

Telomere Length Is Associated with Disability Progression in Multiple Sclerosis.
PubMed 文献 · Ann Neurol · 2019-10-02

调整年龄、病程和性别后,LTL每降低0.2,EDSS高0.27、脑体积低7.4mm³;纵向分析中LTL降低与EDSS升高相关,提示生物学衰老可能参与MS神经损伤。

要点

  • 较短端粒长度与多发性硬化患者残疾程度独立相关,不受实际年龄影响。
  • LTL每降低0.2,EDSS高0.27(95%CI 0.13-0.42,p<0.001)。
  • 靶向衰老相关机制可能是延缓MS进展的潜在治疗策略。

核心结论

  • 较短端粒长度与多发性硬化残疾独立于实际年龄相关,提示生物学衰老可能参与MS神经损伤。

研究设计与样本

  • 加州大学旧金山分校EPIC队列研究,纳入356名女性和160名男性MS/临床孤立综合征患者,平均年龄43岁,中位病程6年,中位EDSS 1.5,平均T/S比0.97(SD=0.18)。

主要发现

  • 调整年龄、病程和性别后,LTL每降低0.2,EDSS高0.27(95%CI 0.13-0.42,p<0.001)。
  • LTL每降低0.2,脑体积低7.4mm³(95%CI 0.10-14.7,p=0.047)。
  • 纵向分析中基线LTL较低者随访EDSS更高、脑体积更低。
  • 子集(n=46)中LTL变化与10年EDSS变化相关,LTL每降低0.2,EDSS高0.34(95%CI 0.08-0.61,p=0.012)。

临床怎么用

  • 端粒长度可作为反映MS生物学衰老与残疾进展风险的潜在生物标志物。
  • 针对衰老相关机制可能成为延缓MS进展的治疗方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether biological aging as measured by leukocyte telomere length (LTL) is associated with clinical disability and brain volume loss in multiple sclerosis (MS). METHODS: Adults with MS/clinically isolated syndrome in the University of California, San Francisco EPIC cohort study were included. LTL was measured on DNA samples by quantitative polymerase chain reaction and expressed as telomere to somatic DNA (T/S) ratio. Expanded Disability Status Scale (EDSS) and 3-dimensional T1-weighted brain magnetic resonance imaging were performed at baseline and follow-up. Associations of baseline LTL with cross-sectional and longitudinal outcomes were assessed using simple and mixed effects linear regression models. A subset (n = 46) had LTL measured over time, and we assessed the association of LTL change with EDSS change with mixed effects models. RESULTS: Included were 356 women and 160 men (mean age = 43 years, median disease duration = 6 years, median EDSS = 1.5 [range = 0-7], mean T/S ratio = 0.97 [standard deviation = 0.18]). In baseline analyses adjusted for age, disease duration, and sex, for every 0.2 lower LTL, EDSS was 0.27 higher (95% confidence interval [CI] = 0.13-0.42, p < 0.001) and brain volume was 7.4mm3 lower (95% CI = 0.10-14.7, p = 0.047). In longitudinal adjusted analyses, those with lower baseline LTL had higher EDSS and lower brain volumes over time. In adjusted analysis of the subset, LTL change was associated with EDSS change over 10 years; for every 0.2 LTL decrease, EDSS was 0.34 higher (95% CI = 0.08-0.61, p = 0.012). INTERPRETATION: Shorter telomere length was associated with disability independent of chronological age, suggesting that biological aging may contribute to neurological injury in MS. Targeting aging-related mechanisms is a potential therapeutic strategy against MS progression. ANN NEUROL 2019;86:671-682.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Krysko KM, Henry RG, Cree BAC, et al. Telomere Length Is Associated with Disability Progression in Multiple Sclerosis. Ann Neurol. 2019. PMID: 31486104. doi:10.1002/ana.25592

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。